Angioplasty versus bare metal stenting for superficial femoral artery lesions

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 6, 2014, Pages

  Chowdhury, Mohammed M ^a   Mclain, Alexander D ^b   Twine, Christopher P ^b  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b ROYAL GWENT HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGRAPHY; ANKLE BRACHIAL INDEX; ARTERY LESION; BARE METAL STENTING; CLINICAL EFFECTIVENESS; HUMAN; INTERMETHOD COMPARISON; META ANALYSIS; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; SUPERFICIAL FEMORAL ARTERY LESION; SYSTEMATIC REVIEW; TREADMILL EXERCISE; TREATMENT OUTCOME; VASCULAR PATENCY; WALKING; AGED; FEMALE; FEMORAL ARTERY; INTERMITTENT CLAUDICATION; MALE; MULTIMODALITY CANCER THERAPY; PERIPHERAL VASCULAR DISEASES; PROCEDURES; STENT;

ANTICOAGULANT AGENT;

AGED; ANGIOPLASTY, BALLOON; ANTICOAGULANTS; COMBINED MODALITY THERAPY; FEMALE; FEMORAL ARTERY; HUMANS; INTERMITTENT CLAUDICATION; MALE; PERIPHERAL VASCULAR DISEASES; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STENTS; VASCULAR PATENCY;

EID: 84926144115     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD006767.pub3     Document Type: Review

References (49)

1. Becquemin JP, Favre JP, Marzelle J, Nemoz C, Corsin C, Leizorovicz A. Systematic versus selective stent placement after superficial femoral artery balloon angioplasty: a multicenter prospective randomized study. Journal of Vascular Surgery 2003;37(3):487-94.
2. Cejna M, Thurnher S, Illiasch H, Horvath W, Waldenberger P, Hornik K, et al.PTA versus Palmaz stent placement in femoropopliteal artery obstructions: a multicenter prospective randomized study. Journal of Vascular and Interventional Radiology 2001;12(1):23-31.
3. Dick P, Wallner H, Sabeti S, Loewe C, Miekusch W, Lammer J, et al.Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions. Catheterization and Cardiovascular Interventions 2009;74(7):1090-5.
4. Bosiers M, Peeters P, Krankenberg H. The Femoral Artery Stenting Trial (FAST): 12-month outcomes. Abstracts from the 2006 SVS Annual Meeting. June 2006.
5. Krankenberg H. FAST (Femoral Artery Stenting Trial): Current evidence in femoral stenting: insights from the FAST trial acute results and 6-month outcomes. Leipzig Interventional Course; 2006 Jan 26-28, Leipzig. 2006.
6. Krankenberg H. FAST: No advantage to nitinol stents in short lesions. Transcatheter Cardiovascular Therapeutics Conference. 2006.
7. Krankenberg H. Randomized comparison of PTA versus femoral artery stenting (FAST): Acute results. Journal of Endovascular Therapy 2005;12(Suppl 1):21-2.
8. Krankenberg H, Schluter M, Steinkamp HJ, Burgelin K, Scheinert D, Schulte KL, et al.Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST). Circulation 2007;116(3):285-92.
9. Grenacher L, Saam T, Geier A, Muller-Hulsbeck S, Cejna M, Kauffmann GW, et al.PTA versus Palmaz stent placement in femoropopliteal artery stenoses: results of a multicenter prospective randomized study (REFSA) [PTA versus Stent bei Stenosen der A. femoralis und A. poplitea: Ergebnisse einer prospektiv randomisierten Multizenterstudie (REFSA)]. Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin 2004;176(9):1302-10.
10. Grimm J, Muller-Hulsbeck S, Jahnke T, Hilbert C, Brossmann J, Heller M. Randomized study to compare PTA alone versus PTA with Palmaz stent placement for femoropopliteal lesions. Journal of Vascular and Interventional Radiology 2001;12(8):935-42.
11. Laird JR, Katzen BT, Scheinert D, Lammer J, Carpenter J, Buchbinder M, et al.Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial. Circulation. Cardiovascular Interventions 2010;3(3):267-76.
12. Laird JR, Katzen BT, Scheinert D, Lammer J, Carpenter J, Buchbinder M, et al.Nitinol stent implantation vs. balloon angioplasty for lesions in the superficial femoral and proximal popliteal arteries of patients with claudication: three-year follow-up from the RESILIENT randomized trial. Journal of Endovascular Therapy 2012;19(1):1-9.
13. Chalmers N, Walker PT, Belli AM, Thorpe AP, Sidhu PS, Robinson G, et al.Randomized trial of the SMART stent versus balloon angioplasty in long superficial femoral artery lesions: the SUPER study. Cardiovascular and Interventional Radiology 2013;36(2):353-61.
14. Sabeti S, Czerwenka-Wenkstetten A, Dick P, Schlager O, Amighi J, Mlekusch I, et al.Quality of life after balloon angioplasty versus stent implantation in the superficial femoral artery: findings from a randomized controlled trial. Journal of Endovascular Therapy 2007;14(4):431-7.
15. Schillinger M, Sabeti S, Dick P, Amighi J, Mlekusch W, Schlager O, et al.Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. Circulation 2007;115(21):2745-9.
16. Schillinger M, Sabeti S, Loewe C, Dick P, Amighi J, Mlekusch W, et al.Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. New England Journal of Medicine 2006;354(18):1879-88.
17. Vroegindeweij D, Vos LD, Tielbeek AV, Buth J, vd Bosch HC. Balloon angioplasty combined with primary stenting versus balloon angioplasty alone in femoropopliteal obstructions: A comparative randomized study. Cardiovascular and Interventional Radiology 1997;20(6):420-5.
18. Zdanowski Z, Albrechtsson U, Lundin A, Jonung T, Ribbe E, Thorne J, et al.Percutaneous transluminal angioplasty with or without stenting for femoropopliteal occlusions? A randomized controlled study. International Angiology 1999;18(4):251-5.
19. Ahn S, Rutherford RB. A multicenter prospective randomized trial to determine the optimal treatment of patients with claudication and isolated superficial femoral artery occlusive disease: conservative versus endovascular versus surgical therapy. Journal of Vascular Surgery 1992;15(5):889-91.
20. Brancaccio G, Lombardi R, Stefanini T, Torri P, Russo D, Gorji N, et al.Comparison of embolic load in femoropopliteal interventions: percutaneous transluminal angioplasty versus stenting. Vascular and Endovascular Surgery 2012;46(3):229-35.
21. Duda SH, Bosiers M, Lammer J, Scheinert D, Zeller T, Oliva V, et al.Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial. Journal of Endovascular Therapy 2006;13(6):701-10.
22. Saxon RR, Coffman JM, Gooding JM, Natuzzi E, Ponec DJ. Long-term results of ePTFE stent-graft versus angioplasty in the femoropopliteal artery: single center experience from a prospective, randomized trial. Journal of Vascular and Interventional Radiology 2003;14(3):303-11.
23. Anonymous. Intracoil® self-expanding peripheral stent PO000033. http://www.accessdata.fda.gov/cdrh_docs/pdf/P000033b.pdf 2001:1-13.
24. Greenberg D, Rosenfield K, Garcia LA, Berezin RH, Lavelle T, Fogleman S, et al.In-hospital costs of self-expanding nitinol stent implantation versus balloon angioplasty in the femoropopliteal artery (the VascuCoil Trial). Journal of Vascular and Interventional Radiology 2004;15(10):1065-9.
25. NCT01183117. A clinical investigation of SM-01 stenting versus PTA for the treatment of superficial femoral artery disease. clinicaltrials.gov/show/NCT01183117 (accessed 10th May 2014).
26. Yokoi H. OSPREY. Occlusive/Stenotic Peripheral artery Revascularization Study. www.leipzig-interventional-course.com/index.php?option=com_content&task=view&id=183&Itemid=286 (accessed June 2013).
27. Acin F, De Haro J, Bleda S, Varela C, Esparza L. Primary nitinol stenting in femoropopliteal occlusive disease: a meta-analysis of randomized controlled trials. Journal of Endovascular Therapy 2012;19(5):585-95.
28. Becker RC, Meade TW, Berger PB, Ezekowitz M, O'Connor CM, Vorchheimer DA, et al.The primary and secondary prevention of coronary artery disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133(6 Suppl):776S-814S.
29. Djulbegovic B, Kumar A, Miladinovic B, Reljic T, Galeb S, Mhaskar A, et al.Treatment success in cancer: industry compared to publicly sponsored randomized controlled trials. PloS One 2013;8(3):e58711.
30. Fontaine VR, Kim M, Kienny R. Surgical treatment for peripheral vascular disease [Die chirurgische Behandlung der peripheren Durchblutungsstorungen]. Helvetica Chirurgica Acta 1954;5/6:499-533.
31. Fowkes FG, Housley E, Cawood EH, Macintyre CC, Ruckley CV, Prescott RJ. Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. International Journal of Epidemiology 1991;20(2):384-92.
32. Frans FA, Bipat S, Reekers JA, Legemate DA, Koelemay MJ. Systematic review of exercise training or percutaneous transluminal angioplasty for intermittent claudication. British Journal of Surgery 2012;99(1):16-28.
33. Greenberg D, Rosenfield K, Garcia LA, Berezin RH, Lavelle T, Fogleman S, et al.In-hospital costs of self-expanding nitinol stent implantation versus balloon angioplasty in the femoropopliteal artery (the VascuCoil Trial). Journal of Vascular and Interventional Radiology 2004;15(10):1065-9.
34. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
35. Kasapis C, Henke PK, Chetcuti SJ, Koenig GC, Rectenwald JE, Krishnamurthy VN, et al.Routine stent implantation vs. percutaneous transluminal angioplasty in femoropopliteal artery disease: a meta-analysis of randomized controlled trials. European Heart Journal 2009;30(1):44-55.
36. Krankenberg H, Schlüter M, Steinkamp HJ, Bürgelin K, Scheinert D, Schulte KL, et al.Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST). Circulation 2007;116(3):285-92.
37. Lundh A, Sismondo S, Lexchin J, Busuioc OA, Bero L. Industry sponsorship and research outcome. Cochrane Database of Systematic Reviews 2012, Issue 12. [DOI: 10.1002/14651858.MR000033.pub2]
38. Mazari FA, Khan JA, Carradice D, Samuel N, Abdul Rahman MN, Gulati S, et al.Randomized clinical trial of percutaneous transluminal angioplasty, supervised exercise and combined treatment for intermittent claudication due to femoropopliteal arterial disease. British Journal of Surgery 2012;99(1):39-48.
39. Mwipatayi BP, Hockings A, Hofmann M, Garbowski M, Sieunarine K. Balloon angioplasty compared with stenting for treatment of femoropopliteal occlusive disease: a meta-analysis. Journal of Vascular Surgery 2008;47(2):461-9. [PUBMED: 17950563]
40. National Institute for Health and Clinical Excellence. Lower limb peripheral arterial disease: diagnosis and management. www.nice.org.uk/nicemedia/live/13856/60428/60428.pdf (accessed 16th May 2014).
41. Norgren L, Hiatt WR, Dormany JA, Nehler MR, Harris KA, Fowkes FG, et al.Inter-society consensus for the management of peripheral arterial disease (TASC II). European Journal of Vascular and Endovascular Surgery 2007;33(Suppl 1):S1-75.
42. Rutherford RB, Baker JD, Ernst C, Johnston KW, Porter JM, Ahn S, et al.Recommended standards for reports dealing with lower extremity ischemia: revised version. Journal of Vascular Surgery 1997;26(3):517-38.
43. Sabeti S, Czerwenka-Wenkstetten A, Dick P, Schlager O, Amighi J, Mlekusch I, et al.Quality of life after balloon angioplasty versus stent implantation in the superficial femoral artery: findings from a randomized controlled trial. Journal of Endovascular Therapy 2007;14(4):431-7.
44. Schillinger M, Sabeti S, Loewe C, Dick P, Amighi J, Mlekusch W, et al.Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. New England Journal of Medicine 2006;354(18):1879-88.
45. Schillinger M, Sabeti S, Dick P, Amighi J, Mlekusch W, Schlager O, et al.Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. Circulation 2007;115(21):2745-9.
46. Selvin E, Erlinger TP. Prevelance of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey 1999-2000. Circulation 2004;110(6):738-43.
47. Vardi M, Novack V, Pencina MJ, Doros G, Burke DA, Elmariah S, et al.Safety and efficacy metrics for primary nitinol stenting in femoropopliteal occlusive disease: a meta-analysis and critical examination of current methodologies. Catheterization and Cardiovascular Interventions 2014; Vol. 83, issue 6:975-83. [DOI: 10.1002/ccd.25179]
48. Watson L, Ellis B, Leng GC. Exercise for intermittent claudication. Cochrane Database of Systematic Reviews 2008, Issue 4. [DOI: 10.1002/14651858.CD000990.pub2]
49. Twine CP, Coulston J, Shandall A, McLain AD. Angioplasty versus stenting for superficial femoral artery lesions. Cochrane Database of Systematic Reviews 2009, Issue 2. [DOI: 10.1002/14651858.CD006767.pub2]